Tharimmune, Inc. | WebDisclosure

Basculer en Français

11331	Companies
251853	Keywords
181098	Articles
137639	Press releases

Home
Companies
Tharimmune, Inc.

PRESS RELEASE

published on 05/19/2025 at 14:01, 1 year 5 months ago

Tharimmune Appoints Renowned Counter-Terrorism and Critical Infrastructure Expert James Gordon Liddy (CDR US Navy SEAL (Ret)) as Key Strategic Advisor Against Weaponized Fentanyl and Other High-Potency Opioids Following Positive FDA Feedback
Tharimmune, Inc. appoints James Gordon Liddy as strategic advisor for TH104 development, targeting high-potency opioid exposure. FDA feedback positive for prophylaxis indication

Tharimmune Inc. FDA Feedback High-Potency Opioids James Gordon Liddy TH104 Development
BRIEF

published on 05/06/2025 at 14:06, 1 year 6 months ago

Tharimmune Reports Positive Phase 1 Results for TH104

Tharimmune Inc. FDA Feedback Phase 1 Study Opioid Prophylaxis TH104 Buccal Film
BRIEF

published on 05/06/2025 at 14:06, 1 year 6 months ago

Tharimmune annonce des résultats positifs de phase 1 pour le TH104

Tharimmune Inc. Étude De Phase 1 Commentaires De La FDA Prophylaxie Aux Opioïdes Film Buccal TH104
PRESS RELEASE

published on 05/06/2025 at 14:01, 1 year 6 months ago

Tharimmune Presents Positive Clinical Data Highlighting TH104 Metabolic Profile and Advances Program for Prophylaxis Against Ultrapotent Opioid Exposure Following FDA Feedback
Tharimmune, Inc. presents promising pharmacokinetic and metabolism data of TH104, a buccal film of nalmefene, for prophylaxis against opioid exposure. Study results showcased at Digestive Disease Week 2025

Tharimmune Inc. TH104 Buccal Film Pharmacokinetic Study Opioid Prophylaxis
BRIEF

published on 05/01/2025 at 14:06, 1 year 6 months ago

Le TH104 de Tharimmune sera présenté lors de conférences médicales importantes

Biopharmaceutique TH104 Tharimmune DDW 2025 EASL 2025
BRIEF

published on 05/01/2025 at 14:06, 1 year 6 months ago

Tharimmune's TH104 to Be Presented at Notable Medical Conferences

TH104 Biopharmaceutical Tharimmune DDW 2025 EASL 2025
PRESS RELEASE

published on 05/01/2025 at 14:01, 1 year 6 months ago

Tharimmune Abstracts Accepted for Presentation at Upcoming DDW and EASL Conferences
Tharimmune, Inc. announces presentation of clinical data on lead drug TH104 at DDW and EASL Annual Meetings in May 2025, addressing unmet medical needs in immunology & inflammation

Tharimmune Inc. TH104 Clinical Data Immunology Unmet Medical Needs
BRIEF

published on 04/30/2025 at 14:06, 1 year 6 months ago

Tharimmune élargit son conseil d'administration avec de nouvelles nominations

Stratégie De Croissance Biopharmaceutique Direction Nominations Au Conseil D'administration Tharimmune
BRIEF

published on 04/30/2025 at 14:06, 1 year 6 months ago

Tharimmune Expands Board with New Appointments

Growth Strategy Biopharmaceutical Leadership Board Appointments Tharimmune
PRESS RELEASE

published on 04/30/2025 at 14:01, 1 year 6 months ago

Tharimmune Appoints Clay Kahler and Gary Stetz to its Board of Directors
Tharimmune, Inc. appoints Clay Kahler and Gary Stetz to its Board of Directors, expanding to 9 members. Kahler brings life sciences expertise while Stetz contributes financial acumen

Board Of Directors Financial Expertise Tharimmune Clay Kahler Gary Stetz

Accesswire

Published on 11/12/2026 at 22:30, 13 minutes ago

Bluejay Diagnostics Reports Third Quarter 2026 Financial Results and Provides Business Update
Published on 11/12/2026 at 19:20, 3 hours 23 minutes ago

HELLENiQ ENERGY Holdings S.A Announces 3Q 2026 Financial Results
Published on 11/12/2026 at 15:55, 6 hours 48 minutes ago

DIAGENS Leads in Two Major Global AI Benchmarks and Extends Chest and Abdominal CT Analysis to 509 Imaging Targets, Ushering in a New Era for Medical Imaging AI
Published on 11/12/2026 at 14:31, 8 hours 12 minutes ago

First Breach Inc. Announces Third Quarter 2026 Earnings Conference Call
Published on 11/12/2026 at 14:00, 8 hours 43 minutes ago

GameSquare Announces Peaky Blinders Digital Fan Experience, Advancing the Company's IP Monetization Strategy

View all ACCESSWIRE

EQS Group

Published on 11/12/2026 at 22:35, 8 minutes ago

Silverfort Named a Leader in the IDC MarketScape for Worldwide Augmented Identity Security Solutions 2026 Vendor Assessment
Published on 11/12/2026 at 19:50, 2 hours 53 minutes ago

Eurobattery Minerals receives shareholder requests for additional items on the agenda of the upcoming Extraordinary General Meeting
Published on 11/12/2026 at 18:25, 4 hours 18 minutes ago

OMAN AWARDS TWO GREEN HYDROGEN PROJECTS IN DUQM AND LAUNCHES ROUND 4 GREEN-POWERED DATA CENTRE HYDROGEN AUCTION AT COP31
Published on 11/12/2026 at 18:14, 4 hours 29 minutes ago

EQS-Adhoc: HUGO BOSS AG: Daniel Grieder to step down as CEO of HUGO BOSS effective December 31, 2026 - David Epstein appointed as CEO effective January 1, 2027
Published on 11/12/2026 at 18:00, 4 hours 43 minutes ago

E-PANGO: Report de l’audience du 9 novembre 2026 Devant le Tribunal des activités économiques de Paris

Les Echos

Published on 11/12/2026 at 18:36, 4 hours 6 minutes ago

AXA: Information relating to the number of voting rights and shares making up the share capital on 31/10/2026
Published on 11/12/2026 at 18:36, 4 hours 6 minutes ago

AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 31/10/2026
Published on 11/12/2026 at 18:27, 4 hours 15 minutes ago

EMOVA GROUP - Volume d'affaires T4 2025-26
Published on 11/12/2026 at 18:00, 4 hours 43 minutes ago

Information concerning the total number of voting rights and shares in the share capital as of November 12, 2026
Published on 11/12/2026 at 18:00, 4 hours 43 minutes ago

Chiffre d’affaires du 1er semestre 2026-27 : 45,6 M€

View all LES ECHOS COMFI WIRE